1.Expression of WWOX protein and its significance in non-small cell lung cancers.
Yu-long ZHOU ; Yong-jian XU ; Zhen-xiang ZHANG
Chinese Journal of Oncology 2007;29(4):297-297
Adenocarcinoma
;
metabolism
;
pathology
;
Adult
;
Aged
;
Carcinoma, Non-Small-Cell Lung
;
metabolism
;
pathology
;
Carcinoma, Squamous Cell
;
metabolism
;
pathology
;
Female
;
Humans
;
Immunohistochemistry
;
Lung
;
chemistry
;
pathology
;
Lung Neoplasms
;
metabolism
;
pathology
;
Male
;
Middle Aged
;
Oxidoreductases
;
metabolism
;
Sex Factors
;
Smoking
;
Tumor Suppressor Proteins
;
metabolism
;
WW Domain-Containing Oxidoreductase
2.Ethyl acetate-soluble chemical constituents from branch of Hypericum petiolulatum.
Qi ZHAO ; Hai-long ZHANG ; Xue ZHANG ; Xiao-meng LI ; Yu-zhen SUN ; Hang SU
China Journal of Chinese Materia Medica 2015;40(9):1755-1758
The stems and branches of Hypericum petiolulatum were extracted by alcohol and liquid-liquid extraction. Seven furofuran lignans were isolated from the ethyl acetate fraction of ethanol extract of H. petiolulatum by using silica gelchromatography, Sephadex LH-20 chromatography, medium-pressure liquid chromatography and preparative HPLC. Their structures were identified by the spectroscopic methods as pinoresinol (1), medioresinol (2), 8-acetoxypinoresinol (3), epipinoresinol (4), (+)-syringaresinol (5), (+)-1-hydroxysyringaresinol (6) and erythro-buddlenolE (7). All the isolates were firstly found in H. petiolulatum. In the bioassay, compound 7 showed remarkable antioxidative activity inhibiting Fe(+2)-cystine induced rat liver microsomal lipid peroxidation with inhibitory rate 38% at a concentration of 1 x 10(-6) mol · L(-1) (positive control Vit E with the inhibitory rate of 35% at the same concentration).
Animals
;
Antioxidants
;
chemistry
;
isolation & purification
;
pharmacology
;
Drugs, Chinese Herbal
;
chemistry
;
isolation & purification
;
pharmacology
;
Hypericum
;
chemistry
;
Lipid Peroxidation
;
drug effects
;
Microsomes, Liver
;
drug effects
;
metabolism
;
Molecular Structure
;
Oxidative Stress
;
drug effects
;
Plant Stems
;
chemistry
;
Rats
3.Rapid identification of the chemical compounds in the leaves of Solanum nigrum L. based on UHPLC-Q Exactive MS and molecular network technology
Xian-long DONG ; Lin-jiao YANG ; Xue-mei QIN ; Zhen-yu LI
Acta Pharmaceutica Sinica 2023;58(4):1003-1013
The whole herb of
4.Role of serum cystatin C in the prediction of contrast-induced nephropathy after intra-arterial interventions
Wang ZHENG-YU ; Wang YONG-LI ; Wei JIAN ; Jin LONG ; Wang ZHEN-CHANG
Chinese Medical Journal 2020;133(4):408-414
Background:The diagnosis of contrast-induced nephropathy (CIN) is usually based on changes in serum creatinine (sCr).However,sCr has poor sensitivity as a biomarker of kidney injury.The aim of this study was to investigate the usefulness of serum cystatin C (sCysC) to predict CIN after intra-arterial interventions.Methods:A total of 360 consecutive patients underwent intra-arterial procedures using digital subtraction angiography.SCr,sCysC,and estimated glomerular filtration rate were measured at 1 to 2 days before and at 48,72 h,and 7 days after the procedure.Results:Thirty-one patients (8.61%) developed C1N.Receiver operating characteristic (ROC) curve analysis showed that preoperative sCysC levels had good discriminatory power (area under the curve [AUC] =0.634;95 % confidence interval [CI] =0.526-0.743) for evaluating the risk of CIN after an endovascular procedure,with a sensitivity of 53.33% and specificity of 73.70%.ROC analysis showed that sCysC at 48 h after contrast medium administration was predictive of CIN after an endovascular procedure (AUC =0.735;95% CI =0.647-0.822) with satisfactory sensitivity of 74.20% and specificity of 63.90%.Diabetes mellitus was an independent risk factor for CIN (odds ratio =2.778;95% CI =1.045-7.382;P =0.040).Conclusions:SCysC is an appropriate biomarker to predict the occurrence of CIN.Baseline sCysC before an intervention is useful to obtain a preliminary estimate of the risk of CIN.A 48-h cut-off value of sCysC of 0.99 mg/L after an endovascular procedure may help to rule out patients at lower risk of CIN.
5.Therapeutic effect of fibroblast growth factor 21 on NAFLD in MSG-iR mice and its mechanism.
Sheng-Long ZHU ; Zhen-Yu ZHANG ; Gui-Ping REN ; Xian-Long YE ; Lei MA ; Dan YU ; Miao-Miao HAN ; Jing-Zhuang ZHAO ; Tian-Yuan ZHANG ; De-Shan LI
Acta Pharmaceutica Sinica 2013;48(12):1778-1784
This study is to evaluate the therapeutic effect of fibroblast growth factor 21 (FGF21) on NAFLD in MSG-IR mice and to provide mechanism insights into its therapeutic effect. The MSG-IR mice with insulin resistance were treated with high dose (0.1 micromol.kg-1d-1) and low dose (0.025 micromol.kg-1d-1) of FGF21 once a day for 5 weeks. Body weight was measured weekly. At the end of the experiment, serum lipids, insulin and aminotransferases were measured. Hepatic steatosis was observed. The expression of key genes regulating energy metabolism were detected by real-time PCR. The results showed that after 5 weeks treatment, both doses of FGF21 reduced body weight (P<0.01), corrected dyslipidemia (P<0.01), reversed steatosis and restored the liver morphology in the MSG model mice and significantly ameliorated insulin resistance. Additionally, real-time PCR showed that FGF21 significantly reduced transcription levels of fat synthetic genes, decreased fat synthesis and promoted lipolysis and energy metabolism by up-regulating key genes of lipolysis, thereby liver fat accumulation was reduced and liver function was restored to normal levels. In conclusion, FGF21 significantly reduces body weight of the MSG-IR mice, ameliorates insulin resistance, reverses hepatic steatosis. These findings provide a theoretical support for clinical application of FGF21 as a novel therapeutics for treatment of NAFLD.
Animals
;
Body Weight
;
drug effects
;
Dose-Response Relationship, Drug
;
Dyslipidemias
;
metabolism
;
Energy Metabolism
;
drug effects
;
Fatty Liver
;
chemically induced
;
complications
;
Female
;
Fibroblast Growth Factors
;
administration & dosage
;
pharmacology
;
therapeutic use
;
Insulin Resistance
;
Lipolysis
;
drug effects
;
Liver
;
metabolism
;
pathology
;
Male
;
Mice
;
Non-alcoholic Fatty Liver Disease
;
drug therapy
;
Sodium Glutamate
6.Clinical Study on Safety and Efficacy of MicrowaveAblation for Primary Hyperparathyroidism
Ying WEI ; Lili PENG ; Yan LI ; Zhen-long ZHAO ; Ming-an YU
Korean Journal of Radiology 2020;21(5):572-581
Objective:
To evaluate the safety, feasibility, and efficacy of microwave ablation (MWA) for the treatment of primaryhyperparathyroidism (PHPT).
Materials and Methods:
This study enrolled 67 PHPT patients (22 men, 45 women; mean age, 56.0 ± 16.3 years; range, 18–83 years) from January 2015 to December 2018. The laboratory data, including the serum intact parathyroid hormone (iPTH),calcium, phosphorus, and alkaline phosphatase (ALP) levels, were evaluated before MWA and again 2 hours, 1 day, 7 days, 1month, 3 months, 6 months, 12 months, 18 months, and 24 months after.
Results:
Complete ablation was achieved with all 72 hyperplastic parathyroid glands found on the 67 patients enrolled, 64 ofwhom were treated in one session and 3 were treated over two sessions. The technical success rate was 100%. The medianfollow-up time was 13.6 months (range, 10.0–31.1 months). The clinical success rate was 89.4%. The volume reduction ratewas 79.4% at 6 months. Compared to pre-MWA, the serum iPTH, calcium, phosphorus, and ALP levels had significantlyimproved 6 months post-MWA (iPTH, 157.3 pg/mL vs. 39.2 pg/mL; calcium, 2.75 ± 0.25 mmol/L vs. 2.34 ± 0.15 mmol/L;phosphorus, 0.86 ± 0.20 mmol/L vs. 1.12 ± 0.22 mmol/L; ALP, 79 U/L vs. 54 U/L, respectively; all, p < 0.01). Hoarseness wasa major complication in 4 patients (6.0%), but it improved spontaneously within 2–3 months.
Conclusion
MWA is safe, feasible, and effective for the treatment of PHPT.
7.Construction of a lentiviral vector containing human NESG1 gene and its expression in 293FT cells.
Zhen LIU ; Yan ZHEN ; Xiao-li YU ; Qing-ping JIANG ; Jie LONG ; Wei-yi FANG
Journal of Southern Medical University 2011;31(1):65-68
OBJECTIVETo construct a lentiviral vector carrying human NESG1-EGFP gene and observe its expression in 293FT cells.
METHODSThe CDS region of NESG1 gene was amplified from a plasmid containing the full-length NESG1 sequence and cloned into the lentiviral vector pGC-FU-EGFP by restriction endonuclease AgeI digestion and T(4) DNA ligase ligation. After transformation into competent E. coli cells, the candidate clones were identified by PCR and sequencing. The recombinant plasmid and the two packaging plasmids were co-transfected into human embryonic kidney cell line 293FT cells by lipofectamine 2000 to produce the lentiviral particles, and the viral titer was determined. The 293FT cells were infected by the lentiviral particles obtained and the transfection efficiency was assessed under fluorescent microscope. Western blotting was used to detect the expression of NESG1 protein in the transfected cells.
RESULTSThe lentiviral vector pGC-FU-NESG1-EGFP for NESG1 gene was constructed successfully. Strong green fluorescence was observed in 293FT cells under fluorescent microscope after co-transfection of the cells with the 3 plasmids of lentiviral vector. The virus in the supernatant reached a titer of 2×10(7) TU/ml. The transfection efficiency of the collected virus exceeded 90% in 293FT cells with a multiplicity of infection of 1. Western blotting identified the presence of NESG1 expression in the transfected 293FT cells.
CONCLUSIONThe lentiviral vector for NESG1 has been successfully constructed with a high yield of lentivirus, which facilitate further investigation of the roles of NESG1 gene in the development and progression of nasopharyngeal carcinoma.
Cell Line ; Genetic Vectors ; genetics ; Green Fluorescent Proteins ; genetics ; Humans ; Kidney ; cytology ; embryology ; Lentivirus ; genetics ; metabolism ; Nasopharyngeal Neoplasms ; genetics ; pathology ; Proteins ; genetics ; metabolism ; Recombinant Fusion Proteins ; biosynthesis ; genetics ; Transfection
8.Clinical efficacy of compound glycyrrhizin tablets in the treatment of children with nonalcoholic fatty liver disease.
Yu-Wen LI ; Yu-Hua HU ; Tian-Tian ZHU ; An-Zhen CHU ; Chuan-Long ZHU
Chinese Journal of Contemporary Pediatrics 2017;19(5):505-509
Department of Pediatrics, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China. zhuchuanlong@jsph.org.cn.
Adolescent
;
Child
;
Female
;
Glycyrrhizic Acid
;
therapeutic use
;
Humans
;
Male
;
Non-alcoholic Fatty Liver Disease
;
drug therapy
;
Tablets
9.Influence of glucose-insulin-potassium on the levels of inflammatory cytokines and prognosis of MODS in the scalded rats.
Zhan-ke WANG ; Lin-shui XU ; Shi-liang WANG ; Long-yan LIU ; Xin-yong HU ; Zhong-zhen ZHU ; Yu-zhen ZHANG ; Xiao-ping XIONG ; Wen YU
Chinese Journal of Burns 2005;21(6):422-425
OBJECTIVETo evaluate the influence of glucose-insulin-potassium treatment (GIK) on the levels of inflammatory cytokines in the scalded rats with MODS.
METHODSOne hundred and twenty Sprague Dawley rats were inflicted with 30% TBSA full-thickness scalding, and MODS model was reproduced with intraperitoneal injection of endotoxin following burn injury. Then the rats were randomly divided into GIK, glucose (G) and control (C) groups, with 40 rats in each group. The serum contents of glucose, lactate acid, TNF-alpha, NO and IL-6 of the rats in the three groups were determined during 1 to 7 PSD, and the mortality rate within 7 PSD was observed.
RESULTSThe serum contents of glucose, lactate acid, TNF-alpha, NO and IL-6 of the rats in the GIK group were obviously lower than those in the other two groups during 1 to 7 PSD (P < 0.01), and reached the lowest level at 6 to 7 PSD (TNF-alpha: 2.37 +/- 0.54 microg/L; IL-6: 0.28 +/- 0.17 microg/L; NO: 29 +/- 9 micromol/L). The content of glucose and lactate acid in G group were obviously higher than those in control group (P < 0.01), but the contents of TNF-alpha, IL-6 and NO content were similar between these two groups (P > 0.05). The mortality in GIK group within 7 PSD was 20.0%, which was evidently lower than that in G (37.5%) and C (47.5%) groups (P < 0.05), while that between G and C groups was similar (P > 0.05).
CONCLUSIONThe administration of GIK might ameliorate sepsis by reducing the levels of inflammatory cytokine after burns and endotoxin challenge.
Animals ; Blood Glucose ; metabolism ; Burns ; complications ; diagnosis ; metabolism ; Cytokines ; metabolism ; Disease Models, Animal ; Glucose ; therapeutic use ; Insulin ; therapeutic use ; Lactic Acid ; blood ; Multiple Organ Failure ; diagnosis ; etiology ; metabolism ; Potassium ; therapeutic use ; Prognosis ; Rats ; Rats, Sprague-Dawley
10.The clinical classification method research of keloid.
Ji-Guang MA ; Jing-Long CAI ; Xian-Lei ZONG ; Jun-Cheng WU ; Zhen-Zhong LIU ; Su LIU ; Yu-Sheng SUN ; Zhi-Hua ZHANG
Chinese Journal of Plastic Surgery 2013;29(6):422-427
OBJECTIVETo explore the clinical classification method of keloids and providing a thread for the treatment of keloids.
METHODSTo summarize the 600 cases of keloid patients we accepted and diagnosed from November 2004 to October 2012, and filling in keloid patients information sheet, recording the keloids form by photographs, analyzing the treatment, putting forward the classification method of keloids in clinic.
RESULTSAccording to the position and quantity that keloids grow, the keloid patients are divided into four major categories:one in single site, one in each site, more than one in single site and more than one in each site; According to the area and thickness of keloids, the keloid single lesion is divided into four subclasses: type of small area and thin, type of small area and thick, type of large areas and thin,type of large areas and thick; According to the number of lesions, keloid multiple lesions is divided into two subgenera: isolated multiple and dispersion multiple, different kinds of keloids suit different methods of treatment.
CONCLUSIONThe clinical classification method of keloids can be used to provide thought for the treatment of keloids, and have a good application value.
Humans ; Keloid ; classification ; pathology ; therapy